Psilocybin - The Trip Treatment - From The New Yorker
The Trip Treatment - The New Yorker: "Annals of Medicine FEBRUARY 9, 2015 ISSUE
The Trip Treatment
Research into psychedelics, shut down for decades, is now yielding exciting results.
BY MICHAEL POLLAN
SHARETWEET
TABLE OF CONTENTS
Psilocybin may be useful in treating anxiety, addiction, and depression, and in studying the neurobiology of mystical experience.
CREDIT ILLUSTRATION BY STEPHEN DOYLE
On an April Monday in 2010, Patrick Mettes, a fifty-four-year-old television news director being treated for a cancer of the bile ducts, read an article on the front page of the Times that would change his death. His diagnosis had come three years earlier, shortly after his wife, Lisa, noticed "
Psilocybin
'via Blog this'
The Trip Treatment
Research into psychedelics, shut down for decades, is now yielding exciting results.
BY MICHAEL POLLAN
SHARETWEET
TABLE OF CONTENTS
Psilocybin may be useful in treating anxiety, addiction, and depression, and in studying the neurobiology of mystical experience.
CREDIT ILLUSTRATION BY STEPHEN DOYLE
On an April Monday in 2010, Patrick Mettes, a fifty-four-year-old television news director being treated for a cancer of the bile ducts, read an article on the front page of the Times that would change his death. His diagnosis had come three years earlier, shortly after his wife, Lisa, noticed "
Psilocybin
'via Blog this'
Comments
Post a Comment